Skip to main content

Advertisement

Log in

Acute immunomodulatory changes during controlled ovarian stimulation: evidence from the first trial investigating the short-term effects of estradiol on biomarkers and B cells involved in autoimmunity

  • Assisted Reproduction Technologies
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

The aim of the present study was to evaluate the in vivo immunomodulatory effects of an acute short-term estradiol (E2) increase on serum levels of B cell-activating factor (BAFF), immunoglobulins (Ig), anti-nuclear antibodies (ANA), and the peripheral B cell phenotype.

Methods

We conducted, at the Infertility Center of the University of Padua, a prospective case–control study on a cohort of infertile normo-responder women (group-A, 63 patients) undergoing controlled ovarian stimulation (COS) compared with an age-matched cohort of normo-ovulatory healthy women (group-B, 39 patients). Three serial blood sample assays were conducted in both groups, at T0, hypothalamic suppression; T1, ovulation induction; and T2, βhCG test in group A, and at T0, 2nd day; T1, 14th day; and T2, 21st day of cycle in group B, and serum levels of E2 and BAFF, BAFF/E2 ratio, circulating IgM, IgG, and IgA, ANA titer, and peripheral B cell phenotype were measured. We compared group-A versus group-B in terms of absolute and E2 normalized values of BAFF at baseline (T0) to verify for possible differences between healthy and infertile women, at T1 to verify for possible differences occurring after spontaneous ovulation versus COS, and at T2 to evaluate differences in serum BAFF levels between pregnant versus non-pregnant patients (considering only group-A) and between non-pregnant women after spontaneous versus COS cycles (group-B versus group-A). In group-A, we also evaluated IgM, IgG, IgA levels, ANA titer, and peripheral B cell phenotype at T0 versus T1 versus T2.

Results

With the exception of E2 levels at T1 (as expected), no significant differences were found between the two groups for all outcome measures. In group-A, BAFF at T0 positively correlated with IgM levels; marginal zone CD19+/CD27+/IgD+ memory B cell compartment tended to be expanded at T1 when compared with T0.

Conclusions

Despite several mechanistic and clinical studies supporting a stimulatory role of E2 on autoimmunity, the acute increase of E2 during COS for infertility treatment does not seem to have a major impact on the immune system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Zen M, Canova M, Campana C, et al. The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev. 2011;10(6):305–10.

    Article  CAS  PubMed  Google Scholar 

  2. Murphy AJ, Guyre PM, Wira CR, Pioli PA. Estradiol regulates expression of estrogen receptor ERalpha46 in human macrophages. PLoS ONE. 2009;4(5), e5539.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Grimaldi CM, Hill L, Xu X, Peeva E, Diamond B. Hormonal modulation of B cell development and repertoire selection. Mol Immunol. 2005;42(7):811–20.

    Article  CAS  PubMed  Google Scholar 

  4. Hughes GC, Choubey D. Modulation of autoimmune rheumatic diseases by oestrogen and progesterone. Nat Rev Rheumatol. 2014;10(12):740–51.

    Article  CAS  PubMed  Google Scholar 

  5. Zen M, Ghirardello A, Iaccarino L, et al. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly. 2010;140(13–14):187–201.

    CAS  PubMed  Google Scholar 

  6. Selmi C, Maria Papini A, Pugliese P, Claudia Alcaro M, Gershwin ME. Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis. Arch Med Sci. 2011;7(3):368–80.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Iaccarino L, Ghirardello A, Zen M, et al. Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus. Reumatismo. 2012;64(5):314–20.

    Article  CAS  PubMed  Google Scholar 

  8. Doria A, Iaccarino L, Sarzi-Puttini P, et al. Estrogens in pregnancy and systemic lupus erythematosus. Ann N Y Acad Sci. 2006;1069:247–56.

    Article  CAS  PubMed  Google Scholar 

  9. Doria A, Iaccarino L, Arienti S, et al. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol. 2006;22(2):234–41.

    Article  CAS  PubMed  Google Scholar 

  10. Doria A, Cutolo M, Ghirardello A, et al. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum. 2002;47(2):202–9.

    Article  CAS  PubMed  Google Scholar 

  11. Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol. 2002;2(7):465–75.

    Article  CAS  PubMed  Google Scholar 

  12. Boulé MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, Rifkin IR. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med. 2004;199(12):1631–40.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Bossen C, Tardivel A, Willen L, et al. Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses. Eur J Immunol. 2011;41(3):787–97.

    Article  CAS  PubMed  Google Scholar 

  14. Groom JR, Fletcher CA, Walters SN, et al. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med. 2007;204(8):1959–71.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Lied GA, Lillestøl K, Valeur J, Berstad A. Intestinal B cell-activating factor: an indicator of non-IgE-mediated hypersensitivity reactions to food? Aliment Pharmacol Ther. 2010;32(1):66–73.

    Article  CAS  PubMed  Google Scholar 

  16. Vincent FB, Morand EF, Schneider P, Mackay F. The BAFF/APRIL system in SLE pathogenesis. Nat Rev Rheumatol. 2014;10(6):365–73.

    Article  CAS  PubMed  Google Scholar 

  17. Gizzo S, Andrisani A, Esposito F, et al. Ovarian reserve test: an impartial means to resolve the mismatch between chronological and biological age in the assessment of female reproductive chances. Reprod Sci. 2014;21(5):632–9.

    Article  PubMed  Google Scholar 

  18. Patrelli TS, Berretta R, Gizzo S, et al. CA 125 serum values in surgically treated endometriosis patients and its relationships with anatomic sites of endometriosis and pregnancy rate. Fertil Steril. 2011;95(1):393–6.

    Article  CAS  PubMed  Google Scholar 

  19. Noventa M, Saccardi C, Litta P, et al. Ultrasound techniques in the diagnosis of deep pelvic endometriosis: algorithm based on a systematic review and meta-analysis. Fertil Steril. 2015;104(2):366–383.e2.

    Article  PubMed  Google Scholar 

  20. Noventa M, Saccardi C, Litta P, et al. Innovative ultrasound techniques for diagnosis of deep pelvic endometriosis: more confusion or a possible solution to the dilemma? Ultrasound Obstet Gynecol. 2015;45(3):355–6. doi:10.1002/uog.14754.

    Article  CAS  PubMed  Google Scholar 

  21. Vitagliano A, Noventa M, Gizzo S. Is it time to consider patients suffering from endometriosis-related infertility as “novel candidates” for targeted peri-conceptional D-chiro inositol supplementation? Hypothesis, rationale and some considerations. J Assist Reprod Genet. 2015;32(3):407–8.

    Article  PubMed  Google Scholar 

  22. Vitagliano A, Noventa M, Gizzo S. Emerging evidence regarding statins use as novel endometriosis targeted treatment: real “magic pills” or “trendy” drugs? Some considerations. Eur J Obstet Gynecol Reprod Biol. 2015;184:125–6.

    Article  PubMed  Google Scholar 

  23. Gizzo S, Noventa M, Nardelli GB. Gardasil administration to hr-HPV-positive women and their partners. Trends Pharmacol Sci. 2013;34(9):479–80.

    Article  CAS  PubMed  Google Scholar 

  24. Gizzo S, Capuzzo D, Zicchina C, et al. Could empirical low-dose-aspirin administration during IVF cycle affect both the oocytes and embryos quality via COX 1–2 activity inhibition? J Assist Reprod Genet. 2014;31(3):261–8.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Gizzo S, Noventa M, Quaranta M, et al. The potential role of GnRH agonists and antagonists in inducing thyroid physio-pathological changes during IVF. Reprod Sci. 2015, In Press.

  26. Gizzo S, Andrisani A, Esposito F, et al. Which luteal phase support is better for each IVF stimulation protocol to achieve the highest pregnancy rate? A superiority randomized clinical trial. Gynecol Endocrinol. 2014;30:1–7.

    Google Scholar 

  27. Le Pottier L, Bendaoud B, Renaudineau Y, Youinou P, Pers JO, Daridon C. New ELISA for B cell-activating factor. Clin Chem. 2009;55(10):1843–51.

    Article  PubMed  Google Scholar 

  28. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood. 2005;105(11):4390–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Costa M, Colia D. Treating infertility in autoimmune patients. Rheumatology (Oxford). 2008;47 Suppl 3:iii38–41.

    Google Scholar 

  30. González DA, Díaz BB, Rodríguez Pérez Mdel C, Hernández AG, Chico BN, de León AC. Sex hormones and autoimmunity. Immunol Lett. 2010;133(1):6–13.

    Article  PubMed  Google Scholar 

  31. Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007;28(5):521–74.

    Article  CAS  PubMed  Google Scholar 

  32. Langer-Gould A, Gupta R, Huang S, et al. Interferon-gamma producing T cells, pregnancy, and postpartum relapses of multiple sclerosis. Arch Neurol. 2010;67(1):51–7.

    Article  PubMed  Google Scholar 

  33. Lockshin MD. Autoimmunity, infertility and assisted reproductive technologies. Lupus. 2004;13(9):669–72.

    Article  CAS  PubMed  Google Scholar 

  34. Hellwig K, Correale J. Artificial reproductive techniques in multiple sclerosis. Clin Immunol. 2013;149(2):219–24.

    Article  CAS  PubMed  Google Scholar 

  35. Doria A, Cutolo M, Ghirardello A, et al. Effect of pregnancy on serum cytokines in SLE patients. Arthritis Res Ther. 2012;14(2):R66.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  36. Bassi N, Luisetto R, Ghirardello A, et al. 17-β-estradiol affects BLyS serum levels and the nephritogenic autoantibody network accelerating glomerulonephritis in NZB/WF1 mice. Lupus. 2015;24(4–5):382–91.

    Article  CAS  PubMed  Google Scholar 

  37. Grimaldi CM, Michael DJ, Diamond B. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol. 2001;167(4):1886–90.

    Article  CAS  PubMed  Google Scholar 

  38. Li Zw, Wen Xf, Wang Y, Luo M, Qiu Jx. Effect of mycophenolic acid and bortezomib on purified human B cells: an in vitro study of long-term functionally stable MICA-sensitized renal recipients. Exp Clin Transplant. 2013;11(6):482–8.

    Article  Google Scholar 

  39. Marder W, Fisseha S, Ganser MA, Somers EC. Ovarian damage during chemotherapy in autoimmune diseases: broad health implications beyond fertility. Clin Med Insights Reprod Health. 2012;2012(6):9–18.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Salvatore Gizzo.

Ethics declarations

Conflict of interest

All authors declare no conflict of interest.

Funding

All authors declare no funding.

Additional information

Capsule The acute short-term estradiol (E2) increase during controlled ovarian stimulation do not seem to significantly affect serum levels of B cell-activating factor (BAFF), immunoglobulins (Ig), anti-nuclear antibodies (ANA), and the peripheral B cell phenotype.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghirardello, A., Gizzo, S., Noventa, M. et al. Acute immunomodulatory changes during controlled ovarian stimulation: evidence from the first trial investigating the short-term effects of estradiol on biomarkers and B cells involved in autoimmunity. J Assist Reprod Genet 32, 1765–1772 (2015). https://doi.org/10.1007/s10815-015-0588-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-015-0588-x

Keywords

Navigation